Viking Therapeutics Target Price

See Viking Therapeutics's analyst price targets ($86) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$34.87

Average Target Price

$86.00

146.6% upside

2 analysts in the last 4 months

High: $89 | Low: $83

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-28	Lake Street	$89	155.2% upside
2026-05-27	Truist FinancialGregory Renza	$83	138% upside
2026-04-30	Morgan Stanley	$95	172.4% upside
2026-04-30	Cantor FitzgeraldSteve Seedhouse	$100	186.8% upside
2026-03-12	JefferiesRoger Song	$101	189.6% upside
2026-02-12	Morgan StanleyMichael Ulz	$99	183.9% upside
2025-11-12	Canaccord GenuityEdward Nash	$107	206.9% upside
2025-10-29	Canaccord GenuityEdward Nash	$106	204% upside
2025-10-23	Morgan Stanley	$102	192.5% upside
2025-10-23	Cantor Fitzgerald	$105	201.1% upside
2025-04-28	Truist FinancialJoon Lee	$75	115.1% upside
2024-12-02	Piper SandlerBiren Amin	$74	112.2% upside
2024-11-04	LaidlawYale Jen	$110	215.5% upside
2024-11-04	JefferiesRoger Song	$110	215.5% upside
2024-06-27	Morgan StanleyMichael Ulz	$105	201.1% upside
2024-06-25	H.C. WainwrightJoseph Pantginis	$90	158.1% upside
2024-05-16	Raymond JamesSteve Seedhouse	$116	232.7% upside
2024-05-16	Truist FinancialJoon Lee	$120	244.1% upside
2024-03-26	Stifel NicolausSamimy Annabel	$95	172.4% upside
2024-03-26	OppenheimerJay Olson	$138	295.8% upside
2024-03-26	BTIGJustin Zelin	$125	258.5% upside
2024-03-15	BTIGJustin Zelin	$100	186.8% upside
2022-12-24	Maxim GroupMaxim Maxim	$15	57% downside
2022-12-19	BTIGJustin Zelin	$20	42.6% downside
2022-12-19	H.C. WainwrightJoseph Pantginis	$21	39.8% downside

Viking Therapeutics (VKTX) FAQ

The latest target price for VKTX is $86. Investors often review this figure alongside Viking Therapeutics's historical trend and sector peers before judging valuation or financial health.

Viking Therapeutics trades near $34.87 while the consensus target sits at $86 (146.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting VKTX's target price ($86), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Viking Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.